New Journal Website is available at:

Published by: Shiraz University of Medical Sciences

Liver Enzymes and Uric acid in Acute Heart Failure

Farveh Vakilian 1 , Abbas Ali Rafighdoost 1 , Amir Hossein Rafighdoost 1 , * , Ahmad Amin 2 and Maryam Salehi 3
Authors Information
1 Preventive Atherosclerotic Research Center, Cardiology Department, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
3 Community Medicine Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Research in Cardiovascular Medicine: November 2015, 4 (4); e22988
  • Published Online: September 26, 2015
  • Article Type: Research Article
  • Received: August 22, 2014
  • Revised: January 1, 2015
  • Accepted: January 22, 2015
  • DOI: 10.5812/cardiovascmed.4(2)2015.22988

To Cite: Vakilian F, Rafighdoost A A, Rafighdoost A H, Amin A, Salehi M. et al. Liver Enzymes and Uric acid in Acute Heart Failure, Res Cardiovasc Med. 2015 ;4(4):e22988. doi: 10.5812/cardiovascmed.4(2)2015.22988.

Copyright: Copyright © 2015, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Gheorghiade M, Filtppatos GS, Felker MG. Braunwald's Heart Disease. 2011; : 517-42
  • 2. Duglas L. Braunwald's Heart Disease. 2011; : 543-78
  • 3. Park HS, Kim H, Sohn JH, Shin HW, Cho YK, Yoon HJ, et al. Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure. Korean J Intern Med. 2010; 25(3): 253-9[DOI][PubMed]
  • 4. Fonarow GC, Adhere Scientific Advisory Committee. . The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003; 4 Suppl 7-30[PubMed]
  • 5. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000; 140(1): 111-20[DOI][PubMed]
  • 6. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003; 82(6): 392-406[DOI][PubMed]
  • 7. Batin P, Wickens M, McEntegart D, Fullwood L, Cowley AJ. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J. 1995; 16(11): 1613-8[PubMed]
  • 8. Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail. 2007; 9(5): 518-24[DOI][PubMed]
  • 9. Hoeper MM, Hohlfeld JM, Fabel H. Hyperuricaemia in patients with right or left heart failure. Eur Respir J. 1999; 13(3): 682-5[PubMed]
  • 10. Hasenfuss G, Teerlink JR. Cardiac inotropes: current agents and future directions. Eur Heart J. 2011; 32(15): 1838-45[DOI][PubMed]
  • 11. Goldhaber JI, Hamilton MA. Role of inotropic agents in the treatment of heart failure. Circulation. 2010; 121(14): 1655-60[DOI][PubMed]
  • 12. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008; 54(2): 273-84[DOI][PubMed]
  • 13. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003; 107(15): 1991-7[DOI][PubMed]
  • 14. Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J. 2006; 70(8): 1006-11[PubMed]
  • 15. Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, Perez NG. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail. 2006; 12(7): 491-8[DOI][PubMed]
  • 16. Struthers AD, Donnan PT, Lindsay P, McNaughton D, Broomhall J, MacDonald TM. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart. 2002; 87(3): 229-34[PubMed]
  • 17. Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood. 1997; 89(2): 577-82[PubMed]
  • 18. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005; 172(3): 367-79[DOI][PubMed]
  • 19. Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail. 2006; 8(7): 697-705[DOI][PubMed]
  • 20. van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010; 16(1): 84-90[DOI][PubMed]
  • 21. Nikolaou M, Parissis J, Yilmaz MB, Seronde MF, Kivikko M, Laribi S, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013; 34(10): 742-9[DOI][PubMed]
  • 22. Denis C, De Kerguennec C, Bernuau J, Beauvais F, Cohen Solal A. Acute hypoxic hepatitis ('liver shock'): still a frequently overlooked cardiological diagnosis. Eur J Heart Fail. 2004; 6(5): 561-5[DOI][PubMed]
  • 23. Amin A, Vakilian F, Maleki M. Serum uric acid levels correlate with filling pressures in systolic heart failure. Congest Heart Fail. 2011; 17(2): 80-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader